Summarise effects of pregnancy and breastfeeding on pharmacodynamics and pharmacokinetics.

Pregnancy and Breastfeeding Effects on Pharmacology

Start from one idea. A drug only works if the right concentration reaches the right target for the right length of time. Pharmacokinetics describes what the body does to the drug — how much gets in, where it goes, how fast it leaves (the ADME sequence: absorption, distribution, metabolism, elimination). Pharmacodynamics describes what the drug does to the body — how strongly the target tissue responds. Everything in this chapter is just those two ideas applied to a body that is temporarily running a second circulation.

Pregnancy and breastfeeding therefore do not make pharmacology simpler. They add compartments, altered physiology, fetal development, neonatal clearance and maternal disease risk. The mother's plasma volume, blood flow, kidney function, liver enzymes and protein levels all shift, so the same dose can produce a different concentration. A placenta now sits between mother and fetus as a living filter. After delivery the milk becomes a third route of exposure. The safe prescribing question is therefore never just "is it safe?" The better question is:

What disease is being treated, at what gestation, with what drug exposure, what fetal or infant vulnerability, and what risk if the mother is undertreated?

The most dangerous mistake is reflexive stopping of effective treatment because the patient is pregnant. Untreated epilepsy, HIV, TB, severe hypertension, sepsis, diabetes, asthma, autoimmune disease or psychiatric illness may be more dangerous than a carefully chosen medicine. The second dangerous mistake is false reassurance without timing, dose and indication. The whole chapter builds from maternal physiology, to the placenta, to the fetus, to the milk, and finally to a prescribing framework that ties them together.

Maternal Physiology Changes Exposure

Pregnancy changes pharmacokinetics from the first trimester onward, but not every drug changes in the same direction.

Pregnancy also changes pharmacodynamics. The myometrium becomes more responsive to contractile signals toward term. The respiratory system has less reserve, so sedating drugs and sepsis matter. The coagulation system is prothrombotic, changing the risk-benefit of oestrogen, anticoagulation and immobility. The cardiovascular system tolerates vasodilation differently, especially in haemorrhage or severe pre-eclampsia.

Direction matters more than memorising a list. Work through the ADME steps one at a time:

• Absorption. Progesterone relaxes gastrointestinal smooth muscle, so gastric emptying and gut transit slow. A drug that is normally absorbed quickly (paracetamol is the classic example) reaches a lower, later peak; a drug that is normally absorbed slowly can end up with more total absorption because it dwells longer in the gut. Raised cardiac output and minute ventilation also speed absorption of inhaled and intramuscular drugs.
• Distribution. Plasma volume rises by roughly 40–50% and total body water by 6–8 litres, so the apparent volume of distribution increases for almost every drug. Water-soluble drugs are diluted into a larger space. Fat mass also rises, giving lipophilic drugs a deeper reservoir, so their plasma half-life can be prolonged even when clearance is high.
• Protein binding. Serum albumin falls by about 20% (roughly 5–10 g/L) through dilution and shifting synthesis, while free fatty acids rise and compete for the same binding sites. The result is a higher free fraction of acidic, albumin-bound drugs (phenytoin, valproate, salicylates). α1-acid glycoprotein, which binds basic drugs, changes little in the mother but sits across a steep maternal-to-fetal gradient that shapes transfer.
• Metabolism. Oestrogen-driven enzyme changes are not uniform. Several cytochrome P450 isoenzymes (notably CYP3A4, CYP2D6 and CYP2C9) and the conjugating enzyme UGT1A4 are induced, so substrates of those pathways are cleared faster; a few enzymes (such as CYP1A2) are suppressed, so their substrates accumulate. This is why a single sentence like "pregnancy speeds metabolism" is wrong — it is pathway-specific.
• Elimination. Renal plasma flow and glomerular filtration rate rise by about 50% from the first trimester. Renally cleared drugs (many beta-lactam antibiotics, lithium, low-molecular-weight heparin) are eliminated faster, so a standard dose can become subtherapeutic.

The important Primary distinction is between a changed measured concentration and a changed effect-site exposure. Total phenytoin, for example, may fall partly because albumin falls; the free concentration is what drives effect and toxicity, so a "low" total level can be misleading and free-level (or clinical) monitoring is preferred. A hydrophilic antibiotic may have a lower peak because plasma and extracellular water have expanded; inadequate early exposure in sepsis is dangerous. A renally cleared medicine may disappear faster because GFR rises. The exam answer should therefore name the drug's usual route of elimination and binding before claiming that "pregnancy increases clearance".

Route matters as much as class. Hyperemesis can make oral treatment unreliable. Severe sepsis, eclampsia, haemorrhage and hypertensive emergency often require parenteral therapy because absorption, perfusion and time-to-effect are part of the pharmacology.

Timing Determines Developmental Risk